Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-06-01T13:34:36.624Z Has data issue: false hasContentIssue false

Chapter 16 - Inflammation and Metabolic Issues in Mood Disorders

Published online by Cambridge University Press:  16 May 2024

By
Marsal Sanches  and
Jair C. Soares
Edited by
Allan Young ,
Marsal Sanches ,
Jair C. Soares  and
Mario Juruena
Allan Young
Affiliation:
Institute of Psychiatry, King's College London
Marsal Sanches
Affiliation:
Baylor College of Medicine, Texas
Jair C. Soares
Affiliation:
McGovern Medical School, The University of Texas
Mario Juruena
Affiliation:
King's College London
Get access

Summary

Over the past few decades, the role of inflammation in the pathophysiology of depressive disorder and bipolar disorder has been the focus of considerable attention. In this chapter, we provide an update on the association between inflammatory processes and mood disorders, in light of available evidence. The pathophysiological and clinical implications of this association are critically discussed, as well as the interaction between inflammation, metabolic abnormalities, and medical comorbidities, which have important prognostic consequences for patients with mood disorders.

Keywords

inflammationdepressive disorderbipolar disordermetabolic syndrometraumacytokines
Type
Chapter
Information
Clinical Textbook of Mood Disorders , pp. 163 - 171
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Harrison, PJ, Geddes, JR, Tunbridge, EM. The emerging neurobiology of bipolar disorder. Trends Neurosci. 2018 Jan;41(1):18–30.CrossRefGoogle ScholarPubMed
Sanches, M, Keshavan, MS, Brambilla, P, Soares, JC. Neurodevelopmental basis of bipolar disorder: a critical appraisal. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1617–27.CrossRefGoogle ScholarPubMed
Kraus, C, Castrén, E, Kasper, S, Lanzenberger, R. Serotonin and neuroplasticity – links between molecular, functional and structural pathophysiology in depression. Neurosci Biobehav Rev. 2017 Jun;77:317–26.CrossRefGoogle ScholarPubMed
Bauer, ME, Teixeira, AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437(1):57–67.CrossRefGoogle ScholarPubMed
Beurel, E, Toups, M, Nemeroff, CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020 Jul 22;107(2):234–56.CrossRefGoogle ScholarPubMed
Horrobin, DF, Lieb, J. A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system. Med Hypotheses. 1981 Jul;7(7):891–905.CrossRefGoogle ScholarPubMed
Rosenblat, JD, McIntyre, RS. Bipolar disorder and inflammation. Psychiatr Clin North Am. 2016 Mar;39(1):125–37.CrossRefGoogle ScholarPubMed
Liu, CS, Adibfar, A, Herrmann, N, Gallagher, D, Lanctôt, KL. Evidence for inflammation-associated depression. In Dantzer, R, Capuron, L, editors. Inflammation-Associated Depression: Evidence, Mechanisms and Implications, Vol. 31, Current Topics in Behavioral Neurosciences. Cham: Springer, 2016; 3–30. Available from: http://link.springer.com/10.1007/7854_2016_2CrossRefGoogle Scholar
Mohite, S, Sanches, M, Teixeira, AL. Exploring the evidence implicating the renin-angiotensin system (RAS) in the physiopathology of mood disorders. Protein Pept Lett. 2020;27(6):449–55.CrossRefGoogle Scholar
Galvez, JF, Bauer, IE, Sanches, M, et al. Shared clinical associations between obesity and impulsivity in rapid cycling bipolar disorder: a systematic review. J Affect Disord. 2014 Oct;168:306–13.CrossRefGoogle ScholarPubMed
Banks, WA, Kastin, AJ, Broadwell, RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 1995 Aug;2(4):241–8.Google ScholarPubMed
Singhal, G, Baune, BT. Inflammatory abnormalities in major depressive disorder. In McIntyre, RS, editor. Major Depressive Disorder. Elsevier, 2019; 75–89. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323581318000069Google Scholar
Köhler, CA, Freitas, TH, Maes, M, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017 May;135(5):373–87.CrossRefGoogle ScholarPubMed
Haapakoski, R, Mathieu, J, Ebmeier, KP, Alenius, H, Kivimäki, M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015 Oct;49:206–15.CrossRefGoogle ScholarPubMed
Fiedorowicz, JG, Prossin, AR, Johnson, CP, et al. Peripheral inflammation during abnormal mood states in bipolar I disorder. J Affect Disord. 2015 Nov 15;187:172–8.CrossRefGoogle ScholarPubMed
Guloksuz, S, Cetin, EA, Cetin, T, et al. Cytokine levels in euthymic bipolar patients. J Affect Disord. 2010 Nov;126(3):458–62.CrossRefGoogle ScholarPubMed
van den Ameele S, , van Diermen L, , Staels, W, et al. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: a systematic review. J Affect Disord. 2016 Oct;203:364–73.CrossRefGoogle ScholarPubMed
Duffy, A, Goodday, SM, Keown-Stoneman, C, et al. Epigenetic markers in inflammation-related genes associated with mood disorder: a cross-sectional and longitudinal study in high-risk offspring of bipolar parents. Int J Bipolar Disord. 2019 Dec;7(1):17.CrossRefGoogle ScholarPubMed
Lima Giacobbo, B, Doorduin, J, Klein, HC, et al. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol. 2019 May;56(5):3295–312.CrossRefGoogle ScholarPubMed
Baumeister, D, Akhtar, R, Ciufolini, S, Pariante, CM, Mondelli, V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 2016 May;21(5):642–9.CrossRefGoogle ScholarPubMed
Barbosa, IG, Machado-Vieira, R, Soares, JC, Teixeira, AL. The immunology of bipolar disorder. Neuroimmunomodulation. 2014;21(2–3):117–22.CrossRefGoogle ScholarPubMed
Pace, TWW, Miller, AH. Cytokines and glucocorticoid receptor signaling: relevance to major depression. Ann N Y Acad Sci. 2009 Oct;1179(1):86–105.CrossRefGoogle ScholarPubMed
Vancampfort, D, Vansteelandt, K, Correll, CU, et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013 Mar;170(3):265–74.Google Scholar
Thom, R, Silbersweig, DA, Boland, RJ. Major depressive disorder in medical illness: a review of assessment, prevalence, and treatment options. Psychosom Med. 2019 Apr;81(3):246–55.CrossRefGoogle ScholarPubMed
Halaris, A. Inflammation-associated co-morbidity between depression and cardiovascular disease. Curr Top Behav Neurosci. 2017;31:45–70.CrossRefGoogle ScholarPubMed
Izzi, B, Tirozzi, A, Cerletti, C, et al. Beyond haemostasis and thrombosis: platelets in depression and its co-morbidities. Int J Mol Sci. 2020 Nov 21;21(22):E8817.CrossRefGoogle ScholarPubMed
Limberg, JK, Harrell, JW, Johansson, RE, et al. Microvascular function in younger adults with obesity and metabolic syndrome: role of oxidative stress. Am J Physiol Heart Circ Physiol. 2013 Oct 15;305(8):H1230-1237.CrossRefGoogle ScholarPubMed
Rosenblat, JD, Brietzke, E, Mansur, RB, et al. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord. 2015 Dec 1;188:149–59.CrossRefGoogle ScholarPubMed
Derecki, NC, Cardani, AN, Yang, CH, et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010 May 10;207(5):1067–80.CrossRefGoogle ScholarPubMed
Kauer-Sant’Anna, M, Kapczinski, F, Andreazza, AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009 May;12(4):447–58.Google ScholarPubMed
Berk, M, Post, R, Ratheesh, A, et al. Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. 2017;16(3):236–44.CrossRefGoogle ScholarPubMed
Worthen, RJ, Garzon Zighelboim, SS, Torres Jaramillo, CS, Beurel, E. Anti-inflammatory IL-10 administration rescues depression-associated learning and memory deficits in mice. J Neuroinflammation. 2020 Dec;17(1):246.CrossRefGoogle ScholarPubMed
Kiecolt-Glaser, JK, Wilson, SJ. Psychiatric disorders, morbidity, and mortality: tracing mechanistic pathways to accelerated aging. Psychosom Med. 2016 Sep;78(7):772–5.CrossRefGoogle ScholarPubMed
Lindqvist, D, Epel, ES, Mellon, SH, et al. Psychiatric disorders and leukocyte telomere length: underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev. 2015 Aug;55:333–64.CrossRefGoogle ScholarPubMed
Squassina, A, Pisanu, C, Vanni, R. Mood disorders, accelerated aging, and inflammation: is the link hidden in telomeres? Cells. 2019 Jan 15;8(1):52.CrossRefGoogle ScholarPubMed
Wolkowitz, OM, Mellon, SH, Epel, ES, et al. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress–preliminary findings. PLoS One. 2011 Mar 23;6(3):e17837.CrossRefGoogle ScholarPubMed
Vasconcelos, -Moreno, MP, Fries, GR, Gubert, C, et al. Telomere length, oxidative stress, inflammation and bdnf levels in siblings of patients with bipolar disorder: implications for accelerated cellular aging. Int J Neuropsychopharmacol. 2017 Jun 1;20(6):445–54.Google Scholar
Kramer, NE, Cosgrove, VE, Dunlap, K, et al. A clinical model for identifying an inflammatory phenotype in mood disorders. J Psychiatr Res. 2019 Jun;113:148–58.CrossRefGoogle ScholarPubMed
Moriarity, DP, van Borkulo, C, Alloy, LB. Inflammatory phenotype of depression symptom structure: a network perspective. Brain Behav Immun. 2021 Mar;93:35–42.CrossRefGoogle ScholarPubMed
Chamberlain, SR, Cavanagh, J, de Boer, P, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry J Ment Sci. 2019 Jan;214(1):11–9.CrossRefGoogle ScholarPubMed
Sanches, M, Newberg, AR, Soares, JC. Emerging drugs for bipolar disorder. Expert Opin Emerg Drugs. 2010 Sep;15(3):453–66.CrossRefGoogle ScholarPubMed
Nery, FG, Monkul, ES, Hatch, JP, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol. 2008 Mar;23(2):87–94.CrossRefGoogle ScholarPubMed
Akhondzadeh, S, Jafari, S, Raisi, F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607–11.CrossRefGoogle ScholarPubMed
Scapagnini, G, Davinelli, S, Drago, F, De Lorenzo, A, Oriani, G. Antioxidants as antidepressants: fact or fiction? CNS Drugs. 2012 Jun 1;26(6):477–90.CrossRefGoogle ScholarPubMed
di Michele, F, Talamo, A, Niolu, C, Siracusano, A. Vitamin D and N-acetyl cysteine supplementation in treatment-resistant depressive disorder patients: a general review. Curr Pharm Des. 2020;26(21):2442–59.CrossRefGoogle ScholarPubMed
Yalin, N, Young, AH. Pharmacological treatment of bipolar depression: what are the current and emerging options? Neuropsychiatr Dis Treat. 2020;16:1459–72.CrossRefGoogle ScholarPubMed
Fernandes, BS, Dean, OM, Dodd, S, Malhi, GS, Berk, M. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. J Clin Psychiatry. 2016 Apr;77(4):e457-466.CrossRefGoogle ScholarPubMed
Bauer, IE, Green, C, Colpo, GD, et al. A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression. J Clin Psychiatry. 2018 Dec 4;80(1).CrossRefGoogle ScholarPubMed
Calder, PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013 Mar;75(3):645–62.CrossRefGoogle ScholarPubMed
Appleton, KM, Sallis, HM, Perry, R, Ness, AR, Churchill, R. Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev. 2015;11:CD004692.Google Scholar
Bozzatello, P, Rocca, P, Mantelli, E, Bellino, S. Polyunsaturated fatty acids: what is their role in treatment of psychiatric disorders? Int J Mol Sci. 2019 Oct 23;20(21):E5257.CrossRefGoogle ScholarPubMed
McIntyre, RS, Subramaniapillai, M, Lee, Y, et al. Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I/II depression: a randomized clinical trial. JAMA Psychiatry. 2019 Aug 1;76(8):783–90.CrossRefGoogle ScholarPubMed
Ignácio, ZM, da Silva, RS, Plissari, ME, Quevedo, J, Réus, GZ. Physical exercise and neuroinflammation in major depressive disorder. Mol Neurobiol. 2019 Dec;56(12):8323–35.CrossRefGoogle ScholarPubMed
Metsios, GS, Moe, RH, Kitas, GD. Exercise and inflammation. Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101504.CrossRefGoogle ScholarPubMed
Ost, M, Coleman, V, Kasch, J, Klaus, S. Regulation of myokine expression: role of exercise and cellular stress. Free Radic Biol Med. 2016 Sep;98:78–89.CrossRefGoogle ScholarPubMed
Blumenthal, JA, Babyak, MA, Doraiswamy, PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007 Oct;69(7):587–96.CrossRefGoogle ScholarPubMed
Ravindran, AV, Balneaves, LG, Faulkner, G, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. Can J Psychiatry Rev Can Psychiatr. 2016 Sep;61(9):576–87.Google Scholar
Bauer, IE, Gálvez, JF, Hamilton, JE, et al. Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: a systematic review. J Psychiatr Res. 2016 Mar;74:1–7.CrossRefGoogle ScholarPubMed
Melo, MCA, Daher, EDF, Albuquerque, SGC, de Bruin, VMS. Exercise in bipolar patients: a systematic review. J Affect Disord. 2016 Jul 1;198:32–8.CrossRefGoogle ScholarPubMed
Gondalia, S, Parkinson, L, Stough, C, Scholey, A. Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy. Psychopharmacology (Berl). 2019 May;236(5):1433–43.CrossRefGoogle ScholarPubMed
Null, G, Pennesi, L. Diet and lifestyle intervention on chronic moderate to severe depression and anxiety and other chronic conditions. Complement Ther Clin Pract. 2017 Nov;29:189–93.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×